Midodrin Zentiva (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Midodrin Zentiva, is a Alpha-1 adrenergic agonist presented as a oral tablet for oral use. It is indicated for the treatment of orthostatic hypotension in adult patients, helping to raise standing blood pressure and reduce dizziness or fainting episodes.

GNH USA supplies Midodrin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. It delivers products through its experienced network of partners.

Midodrine Hydrochloride is used to manage conditions associated with low blood pressure, particularly orthostatic hypotension. - Orthostatic hypotension: increases standing blood pressure and reduces dizziness or fainting episodes. - Neurogenic orthostatic hypotension: improves autonomic regulation of vascular tone in patients with nervous system disorders. - Postural dizziness: alleviates symptoms experienced when moving from sitting or lying to standing. - Hypotensive episodes: helps prevent sudden drops in blood pressure during daily activities. - Syncope related to orthostatic causes: reduces frequency of fainting spells.

Midodrine Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Piloerection: localized goose‑skin appearance. - Urinary retention: difficulty emptying the bladder. - Supine hypertension: elevated blood pressure while lying down. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe hypertension: markedly high blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Angioedema: swelling of face, lips, tongue, or throat. - Allergic reactions: rash, itching, or hives.

When prescribing Midodrine Hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Blood pressure monitoring: check supine and standing pressures before and during therapy. - Cardiovascular disease: avoid in patients with severe organic heart disease or uncontrolled hypertension. - Renal impairment: use caution and adjust dose in moderate to severe renal dysfunction. - Elderly patients: start at low dose and monitor for supine hypertension. - Concomitant antihypertensives: assess risk of additive blood pressure lowering effects. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and heat.

Midodrine Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: may cause excessive vasoconstriction and hypertension. - Other antihypertensive agents: additive blood pressure‑lowering effect. - Diuretics: increase risk of orthostatic hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory heart rate response. - Selective serotonin reuptake inhibitors: potential for increased blood pressure.